Increased FITC fluorescence on LPS stimulated neutrophils cultured in whole blood.
Recently, it has been observed that Annexin V labelling of phosphatidylserine (PS) on non-apoptotic cells can vary in different leukocyte populations and with the activation of cells, due to differences in the absolute level of exposed PS. We have also observed changes in the absolute level of Annexin V-FITC intensity, but under conditions where absolute PS expression did not change. In the present study, we have explored the effect of neutrophil cell activation on Annexin V-FITC fluorescence intensity by comparing alternatively labelled matched antibodies against Annexin V. Human venous whole blood was cultured with and without stimulation with lipopolysaccharide (LPS). Apoptosis in the neutrophil and lymphocyte populations was analyzed by flow cytometry and the intensity of FITC labelling was compared to matched fluorochromes conjugated to the same cell surface markers. There was an increase in the intensity of Annexin V-FITC in non-apoptotic neutrophils when stimulated with LPS, which did not correlate with increased apoptosis. Furthermore, CD65-FITC intensity also increased on activated neutrophils. Activated neutrophils exhibited higher amounts of FITC fluorescence that were not associated with changes in extracellular PS expression. This effect appears to be fluorochrome related, likely due to an increase in the pH surrounding activated neutrophils.
Wilkins
R C
RC
Consumer and Clinical Radiation Protection Bureau, Health Canada, 775 Brookfield Road, Postal Locator 6303B, Ottawa, ON, Canada K1A 1C1.
Bellier
P V
PV
Kutzner
B C
BC
McNamee
J P
JP
D000328:Adult; D017304:Annexin A5 / Q000378:metabolism; D001769:Blood; D002232:Carbocyanines / Q000494:pharmacology; D018929:Cell Culture Techniques / Q000379:methods*; D002478:Cells, Cultured; D016650:Fluorescein-5-isothiocyanate / Q000032:analysis* / Q000737:chemistry*; D005453:Fluorescence; D006801:Humans; D008070:Lipopolysaccharides / Q000494:pharmacology*; D008214:Lymphocytes / Q000276:immunology; D009504:Neutrophils / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D011419:Propidium / Q000494:pharmacology
D017304:Annexin A5; D002232:Carbocyanines; D008070:Lipopolysaccharides; D011419:Propidium; C007392:3,3'-dihexyl-2,2'-oxacarbocyanine; D016650:Fluorescein-5-isothiocyanate